Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The correct classification: Pure GLP-1 agonists: exenatide, liraglutide, lixisenatide, dulaglutide, semaglutide, efpeglenatide, orforglipron Dual GIP/GLP-1 agonists: tirzepatide Triple agonists (GIP/GLP-1/glucagon): retatrutide Retatrutide, approved in early 2026, adds glucagon receptor agonism to the dual GIP/GLP-1 mechanism
If any symptoms persist or worsen, contact your healthcare professional for guidance
Its thoughtful, evidence-based care designed to help patients reach better metabolic health safely and sustainably
You experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction
They are an immune response, not a viral or bacterial condition
By introducing GLP-1 hormone to our body via injection, we signal to our beta cells to produce insulin and control blood sugar levels
US$ 25.61
US$ 28.02
US$ 29.12
